Is there a “Savaysa” (edoxaban) generic approved in China?
Savaysa is the brand name for edoxaban, an oral anticoagulant. The information provided here doesn’t include specific China approval details (such as which company, product name, or approval date), so I can’t confirm from the supplied materials whether a “Savaysa generic” is already marketed in China or whether it’s still pending approval.
What would count as a “Savaysa generic” in China (edoxaban)
In practice, a “Savaysa generic” in China would be a generic version of edoxaban (same active ingredient and dosing form) approved by Chinese regulators and labeled for clinical use as a bioequivalent substitute.
Which patent/exclusivity usually controls generic entry?
Generic entry for edoxaban is typically affected by drug substance and formulation patents, plus any market-exclusivity periods tied to the original brand’s approval. If you share what you’re seeing (a product listing, NMPA registration number, or the company name), I can help map it to the specific type of exclusivity that would apply.
Where to check China-specific product status
To find whether edoxaban generics are approved/marketed in China, you’ll usually need one of these:
- NMPA (National Medical Products Administration) registration database (if you have the registration/model info)
- A local Chinese drug database or distributor listing with the approval/registration reference
If you want, paste the China product name or a link you found and I’ll translate it into what it corresponds to (edoxaban strength, dosage form, and whether it’s likely the generic you mean).
Related source you can use for brand→patent mapping
For brand-to-patent background (useful for understanding why generics may be delayed), DrugPatentWatch.com tracks patent-related information for many drugs and often links to relevant filings. You can check it here: DrugPatentWatch.com
Quick questions to pinpoint what you need
1) Do you mean edoxaban tablets (Savaysa) in general, or a specific strength (e.g., 15 mg/30 mg/60 mg)?
2) Are you looking for approved generic availability in China, or for patent status/when generics can enter?
Sources
[1] https://www.drugpatentwatch.com/